ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5831.45M
Enterprise Value 3955.99M
Trailing P/E 53.85
Forward P/E 111.48
PEG Ratio (5 yr expected) 14.39
Price/Sales (ttm)4.12
Price/Book (mrq)4.21
Enterprise Value/Revenue 34.74
Enterprise Value/EBITDA 612.30

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 7.69%
Operating Margin (ttm)21.81%

Management Effectiveness

Return on Assets (ttm)6.52%
Return on Equity (ttm)8.33%

Income Statement

Revenue (ttm)201.58M
Revenue Per Share (ttm)17.26
Quarterly Revenue Growth (yoy)20.80%
Gross Profit (ttm)134.24M
EBITDA 77.7M
Net Income Avi to Common (ttm)15.34M
Diluted EPS (ttm)1.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)43.01M
Total Cash Per Share (mrq)3.63
Total Debt (mrq)183.51M
Total Debt/Equity (mrq)93.03
Current Ratio (mrq)0.92
Book Value Per Share (mrq)16.65

Cash Flow Statement

Operating Cash Flow (ttm)67.07M
Levered Free Cash Flow (ttm)52.19M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.95
52-Week Change 318.68%
S&P500 52-Week Change 310.00%
52 Week High 372.81
52 Week Low 336.92
50-Day Moving Average 367.22
200-Day Moving Average 357.29

Share Statistics

Avg Vol (3 month) 381.79k
Avg Vol (10 day) 396.44k
Shares Outstanding 511.88M
Float 9.03M
% Held by Insiders 111.39%
% Held by Institutions 181.51%
Shares Short (Mar 29, 2019) 4932.97k
Short Ratio (Mar 29, 2019) 49.95
Short % of Float (Mar 29, 2019) 412.00%
Short % of Shares Outstanding (Mar 29, 2019) 47.85%
Shares Short (prior month Feb 28, 2019) 4835.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jul 18, 2013